Foundation Medicine Inc

0 DAYS LEFT TO SEEK LEAD PLAINTIFF STATUS

Case Summary
Company Name: Foundation Medicine Inc
Stock Symbol : NASDAQ: FMI
Class Period Start: 02/26/2014
Class Period End: 11/03/2015
Lead Plaintiff motion: 09/26/2017
Date Filed: 07/28/2017
Type of Case: Securities Class Action
Court: U.S. District Court for the District of Massachusetts
Summary:

Thieler Law Corp advises investors with losses exceeding $100,000 of the September 26, 2017 lead plaintiff deadline in a class action lawsuit filed against Foundation Medicine Inc (NASDAQ: FMI) (“Foundation” or “the Company”). The suit is pending in the U.S. District Court for the District of Massachusetts and investors, who purchased Foundation Medicine Inc securities between February 26, 2014 and November 3, 2015, have until September 26, 2017 to move for lead plaintiff. You do not need to move for lead plaintiff to be a member of the Class.

If you purchased Foundation Medicine Inc securities during the Class Period, and have losses over $100,000, you may contact Thieler Law Corp by calling at (619) 377 - 4324 or emailing mail@thielerlaw.com . No class has been certified in this case, and if your losses are less than $100,000 you are still a member of the class.

The complaint alleges that during the Class Period defendants made false and misleading statements and/or allegedly failed to disclose that the reimbursement process and likelihood of coverage for Foundation’s tumor tests by Medicare; and the Company’s financial guidance. As a result of these false statements, Foundation common stock traded at artificially inflated prices during the Class Period.

On July 29, 2015, Foundation revealed that “clinical volume growth was affected by slower than anticipated progress towards obtaining a local coverage determination from our regional Medicare Administrative Contractor and by some competitive noise in the market” and that, as such, the Company was “adjusting” its guidance for clinical volume and annual revenues.

On November 3, 2015, Foundation revealed a further revision to the already reduced number of clinical tests it expected to report for 2015.

Following this news, NASDAQ: FMI fell $6.62 per share, to close at $17.31 per share on November 4, 2015.

If you were negatively impacted by your investment in Foundation Medicine Inc securities between February 26, 2014 and November 3, 2015 and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, please contact us for your no-cost evaluation.

Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/

or

Facsimile: +1 (619) 785 – 3185

Transactions
Buy date (mm/dd/yyyy) Number of shares Price per share
Sell date (mm/dd/yyyy) Number of shares Price per share
Please wait...